Evidences showing association of interleukin-1B polymorphisms with increased risk of gastric cancer in an Indian population

Biochemical and Biophysical Research Communications

Volumn 387, Issue 3, 2009, Pages 456-460

  Kumar, Sushil ^a   Kumar, Ashok ^a   Dixit, Vinod Kumar ^b  

^a BANARAS HINDU UNIVERSITY   (India)

^b BANARAS HINDU UNIVERSITY   (India)

Author keywords

Gastric cancer; Helicobacter pylori; IL 1B; IL 1RN; Interleukin; PCR RFLP

Indexed keywords

GENOMIC DNA; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA;

AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE; GENETIC ASSOCIATION; GENOTYPE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INDIAN; INTERLEUKIN 1 BETA GENE; INTERLEUKIN 1 RECEPTOR ANTAGONIST GENE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH BIOPSY; STOMACH CANCER; STOMACH CARCINOGENESIS;

AGED; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INDIA; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK; STOMACH NEOPLASMS;

HELICOBACTER PYLORI;

EID: 68249091103     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.07.033     Document Type: Article

References (22)

1. Marshall B.J., and Warren J.R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1 (1984) 1311-1315
2. Blaser M.J. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J. Infect. Dis. 161 (1990) 626-633
3. Dooley C.P., Cohen H., Fttzgibbons P.L., Bauer M., Appleman M.D., Perez-Perez G.I., and Blaser M.J. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N. Engl. J. Med. 321 (1989) 1562-1566
4. Talley N.J. Chronic (nonerosive) gastritis: pathogenesis and management. Dig. Dis. 7 (1989) 61-75
5. Kekkj M., Ihamaki T., Saukkonen M., Varis K., and Siurala M. Progression of gastritis at a population level: comparison of a long-term follow-up with stochastic analysis of cross-sectional data. Scand. J. Gastroenterol. 15 (1980) 651-655
6. Villako K., and Siurala M. The behaviour of gastritis and related conditions in different population samples. Ann. Clin. Res. 13 (1981) 114-118
7. Strickland R.G., and Mackay I.R. A reappraisal of the nature and significance of chronic atrophic gastritis. Am. J. Dig. Dis. 18 (1973) 426-440
8. Imai T., Kubo T., and Watanabe H. Chronic gastritis in Japanese with reference to high incidence of gastric carcinoma. J. Natl. Cancer Inst. 47 (1971) 179-195
9. Munoz N., Correa P., Cuello C., and Duque E. Histologic types of gastric carcinoma in high- and low-risk areas. Int. J. Cancer 3 (1968) 809-818
10. Al-Moundhri M.S., Al-Nabhani M., Al-Bahrani B., Burney I.A., Al-Madhani A., Ganguly S.S., Al-Yahyaee S.A., and Grant C.S. Interleukin-1β gene (IL-1B) and interleukin-1 receptor antagonist gene (IL-1RN) polymorphisms and gastric cancer risk in an Omani Arab population. Gastric Cancer 9 (2006) 284-290
11. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-first American cancer society award lecture on cancer epidemiology and prevention. Cancer Res. 52 (1992) 6735-6740
12. El-Omar E.M., Carrington M., Chow W.H., McColl K.E.L., Bream J.H., Young H.A., Herrera J., Lissowska J., Yang C.C., Rothman N., Lanyon G., Martin M., Fraumeni J.F., and Rabkin C.S. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404 (2000) 398-402
13. El-Omar E.M., Rabkin C.S., Gammon M.D., Vaughan T.L., Risch H.A., Schoenberg J.B., Stanford J.L., Mayne S.T., Goedert J., Blot W.J., Fraumeni J.F., and Chow W.H. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 124 (2003) 1193-1201
14. Ruzzo A., Graziano F., Pizzagalli F., Santini D., Battistelli V., Panunzi S., Canestrari E., Catalano V., Humar B., Ficarelli R., Bearzi I., Cascinu S., Naldi N., Testa E., and Magnani M. Interleukin-1B gene (IL-1B) and interleukin-1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori negative gastric cancer of intestinal and diffuse histotype. Ann. Onco. 16 (2005) 887-892
15. Vamvakopoulos J., Green C., and Metcalfe S. Genetic control of IL-1beta bioactivity through differential regulation of the IL-1 receptor antagonist. Eur. J. Immunol. 32 (2002) 2988-2996
16. Witkin S.S., Gerber S., and Ledger W.J. Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin. Infect. Dis. 34 (2002) 204-209
17. Rad R., Prinz C., Neu B., Neuhofer M., Zeitner M., Voland P., Schepp I.B.W., and Gerhard M. Synergistic effect of Helicobacter pylori virulence factors interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa. J. Infect. Dis. 188 (2003) 272-281
18. Kumar S., Kumar A., and Dixit V.K. Direct detection and analysis of vacA genotypes and cagA gene of Helicobacter pylori from gastric biopsies by a novel multiplex PCR assay. Diagn. Microbiol. Infect. Dis. 62 (2008) 366-373
19. Zhang W.H., Wang X.L., Zhou J., An L.Z., and Xie X.D. Association of interleukin-1B (IL-1B) gene polymorphisms with risk of gastric cancer in Chinese population. Cytokine 30 (2005) 378-381
20. Takagi A., Deguchi R., Kobayashi K., and Miwa T. Cytokine expressions and H. pylori associated gastric mucosal lesion. Keio. J. Med. 51 (2002) 51-52
21. Saxena A., Prasad K.N., Ghoshal U.C., Krishnani N., Bhagat M.R., and Husain N. Association of Helicobacter pylori and Epstein-Barr virus with gastric cancer and peptic ulcer disease. Scand. J. Gastroenterol. 43 (2008) 669-674
22. Sivaprakash R., Rao U.A., Thyagarajan S.P., Ramathilakam B., and Jayanthi V. Investigation for the prevalence of Helicobacter pylori infection in patients with gastric carcinoma in Madras, India. Jpn. J. Med. Sci. Biol. 49 (1996) 49-56